Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Abbvie Inc

Recent news which mentions Abbvie Inc

< Previous 1 2 Next >
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
Tags Biotech and Pharmaceuticals Business Politics
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags Gilead Sciences Inc Biontech SE Health & Science
From CNBC.com News
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags Markets PepsiCo Inc/ Abbvie Inc
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Business Abbvie Inc Novo Nordisk A/S
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Health & Science LILLY DRN Companies
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Merck & Co Inc LILLY DRN Pharmaceuticals
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Roche Holding AG Johnson & Johnson Social issues
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags Business Markets Alphabet Inc
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Biotechnology Health care industry Amgen Inc
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Vertex Pharmaceuticals Inc Gilead Sciences Inc LILLY DRN
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags Business News Restaurant Brands International Inc McDonald's Corp
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Abbvie Inc Microsoft Corp Novo Nordisk A/S
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Business S&P 500 Abbvie Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Health & Science Merck & Co Inc LILLY DRN
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Advanced Micro Devices Inc Biogen Inc Stock markets
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Markets Abbvie Inc Clover Health Investments Corp
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Intuitive Surgical Inc Meta Platforms Inc Equity Residential
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Business News Bristol/Myers Squibb Co Pharmaceuticals
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Health & Science Healthy Returns Abbvie Inc
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Alvotech SA Abbvie Inc Biotech and Pharmaceuticals
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Business Abbvie Inc Biotech and Pharmaceuticals
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Breaking News: Business Aerospace and defense industry US: News
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Markets Business S&P 500
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Teva Pharmaceutical Industries Ltd Biotech and Pharmaceuticals Business
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Biotechnology Health care industry Pharmaceuticals
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags ImmunoGen Inc Mad Money AstraZeneca PLC
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Health care industry Earnings Business News
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags 5 Things to Know Investing Investment strategy
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Biotech and Pharmaceuticals Cerevel Therapeutics Holdings Inc Abbvie Inc
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Tags Business Abbvie Inc Acquisitions
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.